Cassava Sciences, Inc. FLNA
0.75
(0.02)
(2.60%)
as of 25 Sep
- Market cap
- $37.8M
- P/E
- 0.0×
Follow FLNA
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
2.08 | 2.19 | 2.23 | 2.27 |
+8 more quarters Free account |
Net Debt/EBITDA |
9.04 | 7.92 | 7.24 | 9.04 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.45 | 0.86 | 0.78 | 0.58 | |
Capex/Depreciation |
(0.09) | 0.00 | (1.37) | (0.61) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.08) | (0.18) | (0.21) | (0.13) | |
Cash per Share |
1.71 | 1.79 | 1.98 | 2.20 | |
Shareholders Equity per Share |
1.32 | 1.41 | 1.54 | 1.69 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.32 | 1.41 | 1.54 | 1.69 | |
Free Cash Flow |
(3.88) | (8.88) | (10.25) | (6.30) | |
Working Capital |
43.57 | 47.85 | 53.88 | 60.86 | |
Capital Expenditures |
(0.02) | — | (0.50) | (0.08) | |
Net Current Asset Value |
43.43 | 47.74 | 53.76 | 60.75 | |
| Other line items | |||||
Quick Ratio |
2.06 | 2.16 | 2.18 | 2.21 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.08) | (0.18) | (0.20) | (0.13) | |
Capex per Share |
0.00 | 0.00 | (0.01) | 0.00 | |
Average Payables |
41.06 | 23.69 | 24.65 | 49.17 | |
Average Assets |
119.64 | 124.65 | 137.94 | 176.74 | |
Average Common Equity |
75.79 | 97.88 | 110.05 | 124.10 | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates